臨床外科61巻12号

2006年11月発行

特集 生活習慣病および代謝性疾患と外科

〔生活習慣病および代謝性疾患に対する外科〕

糖尿病―膵島移植の現状と将来展望

著者： 佐藤佳宏¹ 斎籐拓朗¹ 伊勢一哉¹ 見城明¹ 木村隆¹ 後藤満一¹

所属機関： ¹福島県立医科大学外科学第一講座

ページ範囲：P.1487 - P.1492

文献概要

　要旨：わが国におけるⅠ型糖尿病患者への膵島移植は，2003年9月から2006年6月30日までに48回の膵島分離が施行され，23回の移植が13名に行われた．そのうち複数回の移植を受けた3名がインスリンを離脱した．インスリン離脱に至らない患者でも，全例がインスリン投与量の減少と無自覚性低血糖発作からの解放が得られている．わが国で開始された主として心停止ドナーによる膵島移植の成績は，観察期間は短いものの，Ⅰ型糖尿病に対する治療法として可能であることが確認された．今後は長期間の経過観察による良好な成績が期待される．

参考文献

1）Najarian JS, Sutherland DE, Matas AJ, et al：Human islet transplantation：a preliminary report. Transplant Proc 9：233-236, 1977

2）Scharp DW, Lacy PE, Santiago JV, et al：Insulin independence after islet transplantation into typeⅠ diabetic patient. Diabetes 39：515-518, 1990

3）International Islet Transplant Registry：Newsletter # 8. Third Medical Department Center of Internal Medicine Justus-Liebig-University of Giessen, 1999

4）Shapiro AM, Lakey JR, Ryan EA, et al：Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343：230-238, 2000

5）Ryan EA, Paty BW, Senior PA, et al：Five-year follow-up after clinical islet transplantation. Diabetes 54：2060-2069, 2005

6）膵・膵島移植研究会（編）：膵島移植実施マニュアル．第2版．膵・膵島移植研究会，2004

7）北村惣一郎：ヒト組織を利用する医療行為の安全性確保・保存・使用に関するガイドライン．日組織移植会誌3：75-93，2004

8）Matsumoto S, Kuroda Y：Perfluorocarbon for organ preservation before transplantation. Transplantation 74：1804-1809, 2002

9）Venturini M, Angeli E, Maffi P, et al：Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes：the role of US. Radiology 234：617-624, 2005

10）Villiger P, Ryan EA, Owen R, et al：Prevention of bleeding after islet transplantation：lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 5：2992-2998, 2005

11）岩永康裕，興津　輝，野口洋文，他：自験例における膵島移植後の免疫抑制剤副作用の検討．第33回膵・膵島移植研究会，2006/3/17-19，抄録#18

12）Luzi L, Picena Sereni L, Battezzati A, et al：Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Transplantation 75：2018-2023, 2003

13）Lawsin L, Light JA：Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. Transplantation 75：157-160, 2003

14）Lehmann R, Weber M, Berthold P, et al：Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression：two-year follow-up. Am J Transplant 4：1117-1123, 2004

15）Berney T, Bucher P, Mathe Z, et al：Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations. Transplant Proc 36：1121-1122, 2004

16）Fiorina P, Venturini M, Folli F, et al：Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients：beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care 28：1303-1310, 2005

17）Fiorina P, Gremizzi C, Maffi P, et al：Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 28：1358-1365, 2005

18）Andres A, Toso C, Morel P, et al：Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation. Transplant Proc 37：1326-1327, 2005

19）Hering BJ, Kandaswamy R, Harmon JV：Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 4：390-401, 2004

20）Hering BJ, Kandaswamy R, Ansite JD, et al：Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293：830-835, 2005

21）Matsumoto S, Tanaka K, Strong DM：Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation 78：839-843, 2004

22）Matsumoto S, Okitsu T, Iwanaga Y, et al：Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365：1642-1644, 2005

23）Matsumoto S, Okitsu T, Iwanaga Y, et al：Follow up study of the first succeccful living donor islet transplantation. World transplant congress, The first joint international transplant meeting, July 22-27, 2006, Abstract #808

24）Ramiya VK, Maraist M, Arfors KE, et al：Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6：278-282, 2000

25）Bonner-Weir S, Taneja M, Weir GC, et al：In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 97：7999-8004, 2000

26）Seaberg RM, Smukler SR, Kieffer TJ, et al：Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 22：1115-1124, 2004

27）Yang L, Li S, Hatch H, et al：In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A 99：8078-8083, 2002

28）Tang DQ, Lu S, Sun YP, et al：Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1-and Pdx1-VP16 mediated by lentiviral vectors. Lab Invest 86：83-93, 2006

29）Kodama S, Kuhtreiber W, Fujimura S, et al：Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302：1223-1227, 2003

30）Tang DQ, Cao LZ, Burkhardt BR, et al：In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53：1721-1732, 2004

31）Baeyens L, De Breuck S, Lardon J, et al：In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48：49-57, 2000

32）Minami K, Okuno M, Miyawaki K, et al：Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc Natl Acad Sci U S A 102：15116-15121, 2005,

33）Gershengorn MC, Hardikar AA, Wei C, et al：Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306：2261-2264, 2004

34）Ogata T, Li L, Yamada S, et al：Promotion of beta-cell differentiation by conophylline in fetal and neonatal rat pancreas. Diabetes 53：2596-2602, 2004

35）Kojima H, Fujimiya M, Matsumura K, et al：NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 9：596-603, 2003

36）Valdes R：Xenotransplantation trials. Lancet 359：2281, 2002

37）Cardona K, Korbutt GS, Milas Z, et al：Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12：304-306, 2006

38）Check E：Diabetes trial stirs debate on safety of xenotransplants. Nature 419：5, 2002